(Q39410889)

English

Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.

scientific article published on 30 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Irene Bargellini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Francesco Florio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Rita Golfieri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Maurizio Grosso

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Dario Luca Lauretti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Roberto Cioni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

30 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

CardioVascular and Interventional Radiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

438-444

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23719667%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

https://scigraph.springernature.com/pub.10.1007/s00270-013-0656-5

0 references

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Radioembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Response rates to mail surveys published in medical journals

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Is the treatment of hepatocellular carcinoma on the waiting list necessary?

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

1 reference

https://api.crossref.org/works/10.1007%2FS00270-013-0656-5

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39410889&oldid=1501195968"